Literature DB >> 1311750

Immunolocalization of mineralocorticoid receptor in human kidney, pancreas, salivary, mammary and sweat glands: a light and electron microscopic immunohistochemical study.

H Sasano1, K Fukushima, I Sasaki, S Matsuno, H Nagura, Z S Krozowski.   

Abstract

Using a polyclonal antibody against a synthetic fusion protein corresponding to 167 amino acids of the N-terminal region of the human renal mineralocorticoid receptor (MR), an immunohistochemical study was performed to investigate the intraglandular and intracellular localization of the receptor in human kidney, salivary gland, pancreas, mammary gland and sweat gland both at the light and electron microscopic levels. In the kidney, immunoreactivity was observed in distal convoluted tubules, branches of Henle's loop, and collecting tubules in the renal cortex, and papillary and Henle's loops' ducts in the renal medulla. No significant differences in the distribution of immunoreactivity were observed using different fixatives (10% neutral formalin, 100% methanol, 4% paraformaldehyde, PLP (periodate-lysine-2% paraformaldehyde) solution and Zamboni solution) and processing methods (paraffin embedding and frozen sectioning). Immunoreactivity in the kidney was observed in both the cytoplasm and nucleus, with cytoplasmic staining predominant, regardless of the methods of tissue preparation. Immunoelectron microscopy, employing a pre-embedding method, demonstrated the presence of immunoreaction precipitates in nuclei, endoplasmic reticulum, perinuclear cisternae, free cytoplasm and cell membranes. In nuclei, immunoreactivity was observed in euchromatin but not in heterochromatin, which is consistent with an association of MR with specific DNA regulatory elements located in transcriptionally active euchromatin. In other organs, MR was expressed in cells of the excretory ductal system where mineralocorticoids are known to play a role in electrolyte homeostasis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1311750     DOI: 10.1677/joe.0.1320305

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  7 in total

1.  Induction of mineralocorticoid receptor by sodium butyrate in small intestinal (IEC6) and colonic (T84) epithelial cell lines.

Authors:  K Fukushima; I Sasaki; S Sato; H Sasano; Z Krozowski; S Matsuno
Journal:  Dig Dis Sci       Date:  1999-08       Impact factor: 3.199

2.  Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone.

Authors:  Henk Karst; Stefan Berger; Marc Turiault; Francois Tronche; Günther Schütz; Marian Joëls
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-16       Impact factor: 11.205

3.  APRIN is a unique Pds5 paralog with features of a chromatin regulator in hormonal differentiation.

Authors:  Maricel Maffini; Viktoria Denes; Carlos Sonnenschein; Ana Soto; Peter Geck
Journal:  J Steroid Biochem Mol Biol       Date:  2007-09-12       Impact factor: 4.292

4.  Subcellular localization of mineralocorticoid receptors in living cells: effects of receptor agonists and antagonists.

Authors:  G Fejes-Tóth; D Pearce; A Náray-Fejes-Tóth
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

Review 5.  Therapeutic targeting of aldosterone: a novel approach to the treatment of glomerular disease.

Authors:  Andrew S Brem; Rujun Gong
Journal:  Clin Sci (Lond)       Date:  2015-05       Impact factor: 6.124

6.  The role of mineralocorticoids and glucocorticoids under the impact of 11β-hydroxysteroid dehydrogenase in human breast lesions.

Authors:  Mingzhen Cai; Keely McNamara; Yuto Yamazaki; Narumi Harada; Minoru Miyashita; Hiroshi Tada; Takanori Ishida; Hironobu Sasano
Journal:  Med Mol Morphol       Date:  2022-02-01       Impact factor: 2.309

7.  New Insights on the Role of Sodium in the Physiological Regulation of Blood Pressure and Development of Hypertension.

Authors:  Erietta Polychronopoulou; Philippe Braconnier; Michel Burnier
Journal:  Front Cardiovasc Med       Date:  2019-09-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.